Matthias Ocker
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
-
- Nigella sativa pharmacological applications
Papers in
-
- Histone Deacetylase Inhibitors Research 30
- Protein Degradation and Inhibitors 14
- Epigenetics and DNA Methylation 12
- Fibroblast Growth Factor Research 12
- Oncology 30
- Co-authors
- Regine Schneider‐Stock (13 shared papers)Daniel Neureiter (49 shared papers)Hala Gali‐Muhtasib (8 shared papers)Pietro Di Fazio (28 shared papers)C. Herold (20 shared papers)Marion Ganslmayer (16 shared papers)Amr Amin (2 shared papers)Karl Quint (19 shared papers)
- Journals
- Cancer Research (13 papers)International Journal of Oncology (7 papers)Journal of Hepatology (5 papers)Expert Opinion on Investigational Drugs (5 papers)World Journal of Gastroenterology (4 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Matthias Ocker
160 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 120
- Toxicology 327
- Complementary and alternative medicine 452
- Molecular Biology 2.6k
- Cancer Research 536
- Oncology 911
Countries citing papers authored by Matthias Ocker
This map shows the geographic impact of Matthias Ocker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ocker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ocker more than expected).
Fields of papers citing papers by Matthias Ocker
This network shows the impact of papers produced by Matthias Ocker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ocker. The network helps show where Matthias Ocker may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Ocker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 233 | |
| 2 | 2007 | 221 | |
| 3 | 2002 | 163 | |
| 4 | 2020 | 161 | |
| 5 | 2009 | 160 | |
| 6 | 2007 | 137 | |
| 7 | 2008 | 133 | |
| 8 | 2002 | 131 | |
| 9 | Overview of major classes of plant-derived anticancer drugs. | 2009 | 122 |
| 10 | 2009 | 105 | |
| 11 | 2012 | 105 | |
| 12 | 2009 | 103 | |
| 13 | 2011 | 100 | |
| 14 | 2011 | 99 | |
| 15 | 2008 | 84 | |
| 16 | 2012 | 83 | |
| 17 | 2019 | 74 | |
| 18 | 2012 | 72 | |
| 19 | 2013 | 72 | |
| 20 | 2012 | 72 |
About Matthias Ocker
Matthias Ocker is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Epidemiology and Cancer Research, having authored 161 papers that have together received 5.1k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (30 papers), Protein Degradation and Inhibitors (14 papers), Cancer Mechanisms and Therapy (13 papers), Epigenetics and DNA Methylation (12 papers), Fibroblast Growth Factor Research (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and Liver physiology and pathology (8 papers). The work is most often cited by research in Toxicology (327 citations), Complementary and alternative medicine (452 citations), Molecular Biology (2.6k citations), Cancer Research (536 citations) and Oncology (911 citations). Matthias Ocker has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Regine Schneider‐Stock, Daniel Neureiter, Hala Gali‐Muhtasib, Pietro Di Fazio, C. Herold, Marion Ganslmayer, Amr Amin, Karl Quint, Detlef Schuppan and Roberta Montalbano. Their work appears in journals such as Cancer Research, International Journal of Oncology, Journal of Hepatology, Expert Opinion on Investigational Drugs and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.